• Journal of critical care · Apr 2021

    Letter Observational Study

    COVID-19 and non-COVID ARDS patients demonstrate a distinct response to low dose steroids- A retrospective observational study.

    • Alessia Longobardo, Timothy Arthur Chandos Snow, Cecilia Montanari, Robert Shulman, Mervyn Singer, and Nishkantha Arulkumaran.
    • Bloomsbury Institute of Intensive Care Medicine, University College London, UK.
    • J Crit Care. 2021 Apr 1; 62: 464846-48.

    AbstractPatients with COVID-19 ARDS have distinct physiological and immunological phenotypes compared to patients with non-COVID ARDS. Patients with COVID-19 ARDS (n = 32) had a significant improvement in PaO2: FiO2 ratio (p = 0.046) following low-dose steroid treatment, unlike patients with non-COVID ARDS (n = 16) (p = 0.529). Patients with COVID-19 ARDS had a greater fall in CRP compared to patients with non-COVID ARDS, albeit not statistically significant (p = 0.07). Our novel findings highlight differences in the underlying physiological and immunological phenotypes between COVID-19 and non-COVID ARDS, with implications for future ARDS studies.Copyright © 2020 Elsevier Inc. All rights reserved.

      Pubmed     Free full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…